Better Dividend Stock: AbbVie or Johnson & Johnson? [Yahoo! Finance]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Yahoo! Finance
have raised their payouts for over 50 consecutive years, making them members of the small club of Dividend Kings. Though AbbVie and Johnson & Johnson are both great for passive income, these corporations have important differences. Investors on a budget may want to pick just one of these two options, but which one looks like the better dividend stock? The case for AbbVie At first glance, AbbVie doesn't seem like a particularly attractive stock right now. The company's revenue is dropping. Last year, it lost patent protection for what was by far its biggest cash cow -- and one of the most lucrative drugs in the industry's history -- immunology medicine Humira. Even so, AbbVie expects to return to top-line growth in 2025. Its roster of newer medicines is picking up the slack. That's particularly the case with Skyrizi and Rinvoq, which round out the drugmaker's immunology lineup. Together, these medicines will generate $27 billion in revenue by 2027, roughly $6 billion more than Hu
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Kenvue Announces Pricing of Secondary Offering [Yahoo! Finance]Yahoo! Finance
- Funds Linked to Morgan Stanley, Blue Owl Join Bond Sales Blitz [Yahoo! Finance]Yahoo! Finance
- Funds Linked to Morgan Stanley, Blue Owl Join Bond Sales Blitz [BNN Bloomberg (Canada)]BNN Bloomberg
- HIV Drugs Market Size Expected to Reach USD 49.68 Bn by 2032 [Yahoo! Finance]Yahoo! Finance
- Kalderos Names Healthcare Industry Veteran Daryl Todd as Chief Strategy Officer [Yahoo! Finance]Yahoo! Finance
JNJ
Earnings
- 4/16/24 - Beat
JNJ
Sec Filings
- 5/14/24 - Form FWP
- 5/14/24 - Form 424B5
- 5/14/24 - Form FWP
- JNJ's page on the SEC website